Insulet Corp.
PODD
Rangering i aksjer
#2099
Insulet Corporation develops, manufactures, and sells insulin delivery systems... Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Aksjekurs
$140.99
Sist synkronisert: 2026-10-16
Markedsverdi
$9.78B
Endring (1 dag)
1.60%
Endring (1 år)
-55.75%
Land
US
Handel Insulet Corp. (PODD)
Kategori
Healthcare
EPS for Insulet Corp. (PODD)
EPS per June 2026 TTM: $5.36
Ifølge de siste økonomiske rapportene og aksjekursen til Insulet Corp. er selskapets nåværende EPS (TTM) $5.36. Ved slutten av 2023 hadde selskapet en EPS på $2.96, en økning sammenlignet med EPS-en i 2022 som var $0.07.
EPS-historikk for Insulet Corp. fra 2002 til 2026
EPS ved slutten av hvert år
| År | EPS | Endre |
|---|---|---|
| 2026 (TTM) | $5.36 | -10.22% |
| 2024 | $5.97 | 101.69% |
| 2023 | $2.96 | 4,364.56% |
| 2022 | $0.07 | -73.48% |
| 2021 | $0.25 | 127.27% |
| 2020 | $0.11 | -42.11% |
| 2019 | $0.19 | 239.89% |
| 2018 | $0.06 | -112.15% |
| 2017 | $-0.46 | -9.80% |
| 2016 | $-0.51 | -60.47% |
| 2015 | $-1.29 | 38.71% |
| 2014 | $-0.93 | 12.05% |
| 2013 | $-0.83 | -23.15% |
| 2012 | $-1.08 | -11.48% |
| 2011 | $-1.22 | -20.78% |
| 2010 | $-1.54 | -42.54% |
| 2009 | $-2.68 | -20.24% |
| 2008 | $-3.36 | 4.67% |
| 2007 | $-3.21 | -96.76% |
| 2006 | $-99.10 | 39.68% |
| 2005 | $-70.95 | 48.93% |
| 2004 | $-47.64 | 8.57% |
| 2003 | $-43.88 | 3.74% |
| 2002 | $-42.30 | 0.00% |
EPS for lignende selskaper eller konkurrenter
| Selskap | EPS | EPS-forskjell | Land |
|---|---|---|---|
| $3.11 | -41.98% |
US
|
|
| $3.59 | -33.02% |
IE
|
|
| $9.73 | 81.53% |
US
|
|
| $2.48 | -53.73% |
US
|
|
| - | - |
DE
|
